Abacavir lamivudine HIV drug

Abacavir lamivudine HIV drug

C026/1448 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.6MB

Downloadable file size: 5.8MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Abacavir/lamivudinel HIV drug. Box containing tablets of the combination drug abacavir/lamivudine, marketed under the name Kivexa. This drug is a nucleoside reverse transcriptase inhibitor, used as a part of antiretroviral therapy in the treatment of HIV (human immunodeficiency virus). It slows the spread of HIV (human immunodeficiency virus) in the body by inhibiting reverse transcriptase, the enzyme that converts HIV RNA (ribonucleic acid) into viral DNA (deoxyribonucleic acid) that can be incorporated into human cells.

Release details: Model release not required. Property release not required.

Keywords: 21st century, abacavir, abacavir/lamivudine, acquired immune deficiency syndrome, aids, antiretroviral, box, boxed, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, drugs, film-coated, healthcare, hiv, human immunodeficiency virus, kivexa, label, labeled, labelled, labels, lamivudine, medical, medication, medicine, no-one, nobody, nrti, nucleoside reverse transcriptase inhibitor, oral, packaged, packaging, packet, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pills, prescribed, prescription, still life, still-life, tablet, tablets, treatment, viiv healthcare, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.